Clonidine Versus Adenosine to Treat Neuropathic Pain

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest School of Medicine; Wake Forest University Health Sciences
• Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
• Treatments: Adenosine; Adrenergic Agonists; Clonidine

Criteria

Inclusion Criteria:

• Patients with complex regional pain syndrome (CRPS), type I involving a lower extremity

Exclusion Criteria:

• Pregnancy

• Allergy to clonidine

• Currently taking clonidine or other direct a2-adrenergic agonists, or taking cholinesterase inhibitors

• Patients with any serious or unstable medical problems (heart, lung, liver, kidney, or nervous system disease)